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ABSTRACT
In the present work an electrospun nanofibrous membrane composed of 
polyurethane (PU), sodium bicarbonate (NaHCO3) and pantothenic acid (PA) is 
developed for treating chronic wounds. Wounds are a common health problem and 
in particular, the chronic wounds such as vascular ulcers, diabetic ulcers and pressure 
ulcers cause a large number of morbidity and mortality. The main problems of the 
chronic wounds are prolonged inflammation phase and presence of acidic environment. 
These events deactivate the operation of growth factors and also the progression of 
natural healing mechanism. So, various types of advanced textile based dressings 
are developed to address the clinical complications associated with chronic wound 
management. The prepared electrospun scaffolds were characterised to study their 
physicochemical and hemocompatible properties. The SEM micrographs depicted 
continuous, smooth-interconnected nanofibrous morphology of PU-NaHCO3-PA 
scaffolds. The FTIR spectra indicated the addition of N a H C O 3 and PA-based 
hydrophilic chemical groups which significantly enhanced the wettability of the 
composites. Further, the PU-N aH C O 3 -PA composite membrane inferred to have a 
highly porous structure with the mean porosity of 79.4% ±  4.8% which may provide 
a conducive environment for adherence and proliferation of skin cells. The composite 
scaffold also offers a highly hemocompatible surface by delaying coagulation of 
blood through contact activation pathways and by limiting red blood cells damage. 
Therefore, the excellent physicochemical properties, blood compatibility and the 
delivery of PA are anticipated to speed up the impaired healing process of chronic 
wounds.
vABSTRAK
Membran berfiber nano dengan kaedah pusingan elektro yang terdiri daripada 
polyurethane (PU), natrium bikarbonat (NaHCO 3 ) dan asid panthothenic (PA) telah 
dihasilkan bagi tujuan penyembuhan luka kronik. Membran komposit PU-NaHCO 3 - 
PA yang dihasilkan telah diperincikan berdasarkan ciri-ciri fisiokimia menggunakan 
mikroskop electron pengimbas (SEM), spektroskopi transformasi fourier inframerah 
(FTIR), analisis keliangan dan asai sudut sentuhan. Analisis keserasian darah bagi 
komposit yang dihasilkan adalah melalui masa pengaktifan thromboplastin separa 
(APTT), masa prothrombin (PT) dan asai hemolisis. Struktur berfiber nano yang 
selanjar telah diperhatikan melalui SEM bagi fiber bersaiz dalam lingkungan 152 nm ±  
63 nm. Analisis FTIR mengesahkan kehadiran bahan NaH C O 3 dan PA berdasarkan 
ciri-ciri titik tertinggi. Analisis keliangan menunjukkan bahawa membran komposit 
PU-NaHCO3-PA mempunyai keliangan yang tinggi dengan purata sebanyak 79.4% 
±  4.8% dan memberikan persekitaran yang kondusif untuk proses perkembangan sel. 
Selain itu, asai sudut sentuhan menunjukkan bahawa membran yang dihasilkan ini 
mempunyai ciri hidrofilik yang tinggi dengan purata sudut sentuhan sebanyak 74.9° ±
0.5°. Tambahan lagi, membran komposit ini juga menunjukkan keserasian yang tinggi 
dengan darah dengan melengahkan masa bagi APTT dan PT. Nisbah bagi ciri hemolisis 
dengan komposit ini kurang daripada 5%. Membran komposit PU-NaHCO 3 -PA yang 
dihasilkan mempunyai ciri fisiokimia dan keserasian darah yang lebih baik dan boleh 
diekploitasi fungsinya bagi tujuan penyembuhan luka kronik.
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CHAPTER 1
INTRODUCTION
1.1 Overview
A wound could be described as an injury on the skin surface by physical, 
chemical, mechanical or thermal damages. There are two types of wounds in case of 
wound healing: acute and chronic wounds. Acute wounds are caused by traumas and 
usually curable within 8 to 12 weeks. These wounds are often caused by mechanical 
damage, but can be also formed by exposure to extreme heat, irradiation, electrical 
shock or corrosive chemicals [1]. In addition, acute wounds pass well organized 
through all repair mechanism like coagulation, inflammation, formation of granulation 
tissue, and remodelling. In contrast, chronic wounds do not pass all phases of wound 
healing. They often stay in the inflammatory phase and are commonly originated due 
to specific diseases like diabetes or tumors [2]. Moreover, the healing takes more than 
12 weeks and the recurrence of the wounds is possible [1]. Another classification of 
wounds is according to their appearance. There are moist and dry wounds [3]. The 
wound healing of these different types is affected by many parameters. One important 
factor is the pH value. Variations in pH may affect e.g. wound closure, microbial 
infection rates, bacterial virulence and biofilm formation [4]. Several researches show 
that wound healing occurs more effectively at low pH [5]. In case of moist chronic 
wounds studies show different results. Some research groups report that an alkaline 
environment is more advantageous and some refer that an acid environment is more 
beneficial for chronic wound healing. But it is proven that the pH value influences the 
wound healing [4]. Thus, the pH is one important parameter which can be recognized 
in wound treatment. In addition, the treatment of a wound varies depending on the 
type of the wound. Due to the difficulties in treatment of chronic wounds, traditional 
dressings which include cotton, wool, natural or synthetic bandages and gauzes are 
largely replaced by novel advanced dressings. Modern materials which are currently 
utilized for wound healing are natural inert polymers, natural bioactive materials, 
synthetic polymers and hydrogels [3]. Electrospinning is a widely used technique to
2manufacture nanofibers from different natural or synthetic polymers, metal, ceramic 
or glass material. Thus, it has a broad range of applications such as filtration, textiles, 
energy, acoustics, as well as medicine [6].
1.2 Research background
In the past, traditional dressings such as bandages, cotton wool, lint and gauzes 
were used for the management of wounds. These dressings kept the wound dry by 
absorbing the wound exudate and prevented the entry of bacteria into the wound. 
But it has been shown in several studies that a warm and moist wound environment 
is more beneficial for successful wound healing [7]. Thus, advanced dressings are 
developed. They have biological activity on its own or release bioactive ingredients. 
In contrast, solutions, creams, and ointments which include bioactive molecules are 
not very effective for drug delivery to the wounds. Similarly, traditional dressings 
like gauze and cotton wool take no active part in the wound healing process. In 
advanced dressings, cleansing and debriding agents can remove necrotic tissue and 
have an antimicrobial effect which prevents or treats infection and proliferates growth 
factors to aid tissue regeneration. In addition, advanced dressings provide a moist 
environment [3]. Chronic wounds require a specific control of bacterial load and 
moisture level. These facts show that advanced dressings are suitable for the treatment 
of chronic wounds [8]. There are different types of advanced wound dressings which 
can be classified in a number of ways depending on e.g. the function in the wound 
(debridement, antibacterial, occlusive, absorbent, adherence), the type of material 
employed to produce the dressing (hydrocolloid, alginate, collagen) or the physical 
form of the dressing (ointment, film, foam, gel). Furthermore, dressings can be 
ranged into primary, secondary and island dressings. Primary dressings have physical 
contact with the wound, secondary dressings cover the primary dressing and island 
dressings have a central absorbent region which is surrounded by an adhesive portion. 
Classification criteria can be useful to select a dressing for specific wound treatment
[7]. For instance, bioadhesive polymeric (synthetic, semisynthetic, or naturally 
derived) dressings are potentially useful in the treatment of local infection. They can 
achieve increased local concentrations of antibiotics and avoid high-systemic dose to 
reduce the patient exposure. Composite dressings which are made of synthetic and 
natural polymers are also known for controlled drug delivery. The degree of swelling, 
cross-linking density and degradation rate can be controlled, so that delivery kinetics 
are adapted according to the desired drug release. Basically, the drug release from 
polymeric formulations is influenced by some physical processes like hydration of the
3polymer by fluids, swelling to form a gel, diffusion of drug through the polymer matrix 
and eventual erosion of the polymeric system. The contact of a dry polymeric dressing 
with a moist wound surface effects the permeation of the wound moisture into the 
polymer matrix [3].
Polymeric materials were used in the composition of wound dressings. 
They can be divided into natural inert, natural bioactive and synthetic polymers. 
Synthetic polymers commonly used in wound dressings include polyvinylalcohol, 
polyethylene oxide and PU [3]. Their hydrophilic nature procures important functional 
wound healing characteristics e.g. moisture absorption capacity and water vapour 
transmission [8] [3]. In addition, they are generally adhesive, biocompatible and 
has excellent mechanical strength which allows them to stay longer than the natural 
polymers. Hence, the natural or bioactive polymers are widely used in combination 
with synthetic materials which ultimately yields a better wound healing product [3]. 
In tissue engineering, many reports expose the fabrication of electrospun nanofibers 
by using biocompatible polymers for skin, vasculature, heart and cornea as well as 
bone substitutes and nerve regeneration [9], [3]. The suitable properties of electrospun 
nanofibers for biomedical applications consist in their highly porous structure which 
is similar to the structure of extracellular matrix, high levels of gas permeation and 
surface-to-volume ratio [10], [3]. These properties accelerate a lot of healing processes 
such as cell respiration, skin regeneration, moisture retention, removal of exudate and 
hemostasis [10]. Especially, the presence of a high porosity with small pores enables a 
good permeability for oxygen and water, a good adsorption of liquid and protects the 
wound from bacterial penetration and dehydration. In addition, the high surface area 
of the nanofibers support the migration of keratinocytes on the wound surface and can 
improve the healing process. Moreover, nanofibrous materials offer a local delivery of 
therapeutic agents, such as antibiotics or growth factors [3].
Modern materials for chronic wound therapy include hydrocolloids, alginates 
and hydrogels. These ingredients afford a moist environment stimulating wound 
healing. There are several new techniques for the healing of infected ulcers. 
For these methods triphala incorporated collagen is used. Another possibility of 
treatment is the application of an electric field to a flowing medium which forms 
microscale and nanoscale structures to compose functional wound healing materials. 
In more advanced applications, commercial tissue engineered skin agents based on 
acelluar (AllodermTM) or cell containing membranes (Dermagraft TM, ApligraftTM, 
EpicelTM, TransCyteTM, etc.) are developed. But this type of treatment is expensive 
and limited available. The application of biopolymer nanofibers provides a cheap and
4effective alternative for wound treatment and can be used more easily standardized 
[6]. There are already different PU composite membranes for wound healing in 
research e.g. PU-propolis, PU-olive oil/copper oxide nanocrystals, and PU-nitric oxide 
[11, 12, 13]. But there is a research gap regarding particular dressings for chronic 
wounds. In this project, a novel electrospun nanofibrous composite membrane which is 
especially suited to chronic wound healing is developed. The novel membrane includes 
the agents pantothenic acid (PA) and sodium bicarbonate (N aH CO 3) which have cell 
proliferating and antibacterial effects and are already used in chronic wound treatment 
[14, 15, 16].
1.3 Problem statement
Chronic wounds are a global healthcare problem. For instance, in 2011 the 
Center for Disease Control (CDC) assessed that 25.8 million people in the US are 
affected by diabetes mellitus. Fifteen percent of them developed lower extremity ulcers 
and up to 25% of foot ulcer patients will eventually undergo amputation [10]. Each 
year about 1.7 million new cases of diabetes in adults are determined. Thus, it is 
expected that in 2050 one out of every three adults in the United States will have 
diabetes [17]. For this reason it can be inferred that the amount of people affected by 
chronic wounds will also increase.
Previous literature reviews have shown that the treatment of chronic wounds is 
very time-consuming in medical care. The wound healing needs about several months 
or years or never occurs so that amputation could be necessary. In all cases, the therapy 
of chronic wounds is expensive. Although standard materials like gauzes and bandages 
are cheap to manufacture, they have to be changed frequently [18]. Moreover, standard 
materials could be only used if wound healing does not need longer than four weeks. 
Otherwise, alternative methods would be needed [19]. For instance, oxygen-associated 
therapies offer an alternative solution to improve wound healing. In this therapy, a bag 
with pure oxygen which encases the wound is used. Due to the immobility during 
the treatment the oxygen-associated method is very time-consuming and inconvenient 
for the patient. The negative pressure therapy provides a further treatment option. It 
uses PU foam combined with a vacuum pump to reduce the wound area, to provide 
a moist wound environment and to support blood circulation. This method is only 
usable in small wounds. Another disadvantage is arised out of the immobility and 
potential pain during the regular therapy performed by medical staff. Stem cell 
application provides a further solution to treat wounds. It uses a natural material
5which does not result in any side effect but it involves an invasive and very painful 
procedure [3]. Due to the mentioned disadvantages a novel nanofibrous membrane 
suited to the nature of chronic wounds was developed in this study. The production 
of nanofibers could be done using various processing techniques like drawing out, 
molecular self-assembly, thermally induced phase separation or electrospinning. But 
by manufacturing continuous polymeric nanofibers electrospinning is the only method 
which is able to manipulate and control the surface area, fiber diameter, porosity and 
base weight of the membrane [6].
In the present project, a novel nanofibrous composite membrane was developed 
using electrospinning technique. This model was suited to chronic wounds by the 
use of the antibacterial material N aH C O 3 and the cell-proliferating material PA. The 
antibacterial part may help the wound to merge from the inflammatory phase into the 
following proliferation phase. The cell-proliferating part of the novel product may 
support the proliferation phase, so that it may offer promising properties to improve 
the wound healing mechanism and the patient’s compliance, shorten the medical care 
and reduce treatment costs. Therefore, the following problem statements reveal:
1. There is a continuous research to improve nanofibrous composite membranes 
for wound healing.
2. While developing a novel membrane for wound healing the physico-chemical 
properties have to be examined.
3. Blood compatibility is one of the important qualities which has to be evaluated 
for a wound healing membrane.
1.4 Research objectives
Main objectives are:
1. To fabricate and optimize a composite membrane (PU-NaHCO3-PA) for 
wound treatment.
2. To characterize the physico-chemical changes of the composite membrane.
3. To analyse the hemocompatible nature of the composite membrane in order to 
assess its efficacy.
61.5 Scope of the work
Chronic wound healing is a major health issue faced by millions of people. 
The problem of slow healing makes it difficult for patients to recover completely 
and it also involves a continuous medical surveillance [18]. Hence, to reduce the 
economic burden on chronic wounds and improve the patient compliance a cost 
effective nanofibrous composite membrane is proposed in this research. Initially, the 
PU beads will be dissolved using dimethylformamide (DMF) solvent by adapting 
appropriate concentration. Then, the N aH C O 3 and PA composite solution will be 
prepared using suitable solvents. After preparing the PU and PU composite mixtures, 
the electrospinning process will be carried out using optimized flow rate, voltage and 
collector distance. Further to display the physico-chemical properties of prepared 
membranes, characterization tests like scanning electron microscopy (SEM) analysis, 
Fourier transform infrared spectroscopy (FTIR), porosity measurement and contact 
angle assay will be carried out. Finally, the hemocompatibility improvement of the 
composite membrane will be explored through in vitro assays of activated partial 
thromboplastin time (APTT), prothrombin time (PT) and hemolysis.
1.6 Significance of the study
The number of people affected by chronic wounds grows rapidly due to the 
increasing age of population [20][3]. Thus, the risk of delayed wound healing increases 
and the possibility of necessary amputations and in severe cases mortality rises [3]. 
Reports in the United States estimate that $25 billion are spent annually on the 
treatment of chronic wounds. The morbidity and costs of wound care create a need 
for cost-effective wound healing products [20]. A novel membrane suited to chronic 
wounds may improve the success rate of chronic wound healing and thus reduce 
hospital stays, nursing time and costs.
REFERENCES
1. Zahedi, P., Rezaeian, I., Ranaei-Siadat, S.-O., Jafari, S.-H. and Supaphol, P. 
A review on wound dressings with an emphasis on electrospun nanofibrous 
polymeric bandages. Polymers for Advanced Technologies, 2009: n/a.
2. Demidova-Rice, T. N., Hamblin, M. R. and Herman, I. M. Acute and Impaired 
Wound Healing. Advances in Skin & Wound Care, 2012. 25(7): 304-314.
3. Boateng, J. and Catanzano, O. Advanced Therapeutic Dressings for Effective 
Wound Healing-A Review. Journal o f Pharmaceutical Sciences, 2015. 
104(11): 3653-3680.
4. Steven L. Percival, Sara McCarty, John A. Hunt and Emma J. Woods. The 
effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound 
Repair and Regeneration, 2013. (22): 174-186.
5. Gethin, G. The significance of surface pH in chronic wounds. Wounds UK, 
2007. (Vol 3, No 3): 52-56.
6. Dubsky, M., Kubinova, S., Sirc, J., Voska, L., Zajicek, R., Zajicova, A., Lesny, 
P., Jirkovska, A., Michalek, J., Munzarova, M., Holan, V. and Sykova, E. 
Nanofibers prepared by needleless electrospinning technology as scaffolds for 
wound healing. Journal o f Materials Science: Materials in Medicine, 2012. 
23(4): 931-941.
7. Boateng, J. S., Matthews, K. H., Stevens, H. N. and Eccleston, G. M. 
Wound Healing Dressings and Drug Delivery Systems: A Review. Journal 
o f Pharmaceutical Sciences, 2008. 97(8): 2892-2923.
8. Abrigo, M., McArthur, S. L. and Kingshott, P. Electrospun Nanofibers 
as Dressings for Chronic Wound Care: Advances, Challenges, and Future 
Prospects. Macromolecular Bioscience, 2014. 14(6): 772-792.
9. Gharibi, R., Yeganeh, H., Rezapour-Lactoee, A. and Hassan, Z. M. 
Stimulation of Wound Healing by Electroactive, Antibacterial, and 
Antioxidant Polyurethane/Siloxane Dressing Membranes: In Vitro and in Vivo 
Evaluations. ACS Applied Materials & Interfaces, 2015.
10. Rieger, K. A., Birch, N. P. and Schiffman, J. D. Designing electrospun
57
nanofiber mats to promote wound healing -  a review. Journal o f Materials 
Chemistry B, 2013. 1(36): 4531.
11. Kim, J. I., Pant, H. R., Sim, H.-J., Lee, K. M. and Kim, C. S. Electrospun
propolis/polyurethane composite nanofibers for biomedical applications. 
Materials science & engineering. C, Materials for biological applications, 
2014. 44: 52-57.
12. Amna, T., Hassan, M., Yang, J., Khil, M.-S., Song, K.-D., Hwang and Oh,
J.-D. Virgin olive oil blended polyurethane micro/nanofibers ornamented with 
copper oxide nanocrystals for biomedical applications. International Journal 
o f Nanomedicine, 2014: 891.
13. Brisbois, E. J., Bayliss, J., Wu, J., Major, T. C., Xi, C., Wang, S. C., Bartlett,
R. H., Handa, H. and Meyerhoff, M. E. Optimized polymeric film-based nitric 
oxide delivery inhibits bacterial growth in a mouse burn wound model. Acta 
Biomaterialia, 2014. 10(10): 4136-4142.
14. Zhao, J., Liu, S., Li, B., Yang, H., Fan, C. and Cui, W. Stable Acid-
Responsive Electrospun Biodegradable Fibers as Drug Carriers and Cell
Scaffolds. Macromolecular Bioscience, 2013. 13(7): 885-892.
15. Fan, L., Cai, Z., Zhang, K., Han, F., Li, J., He, C., Mo, X., Wang, X. and Wang,
H. Green electrospun pantothenic acid/silk fibroin composite nanofibers: 
Fabrication, characterization and biological activity. Colloids and Surfaces 
B: Biointerfaces, 2014. 117: 14-20.
16. Drake, D. Antibacterial activity of baking soda. Compend Contin Educ Dent
Suppl., 1996. (17(19)): 17-21.
17. Center for Disease Control and Prevention. 2014 Diabetes Report Card.
18. Agarwal, P., Agrawal, P. K., Sharma, D. and Baghel, K. D. Intravenous
infusion for the treatment of diabetic and ischaemic non-healing pedal ulcers. 
Journal o f the European Academy o f Dermatology and Venereology, 2005. 
19(2): 158-162.
19. Frykberg, R. G. and Banks, J. Challenges in the Treatment of Chronic Wounds.
Advances in Wound Care, 2015. 4(9): 560-582.
20. Adolph, E. J., Guo, R., Pollins, A. C., Zienkiewicz, K., Cardwell, N.,
Davidson, J. M., Guelcher, S. A. and Nanney, L. B. Injected biodegradable 
polyurethane scaffolds support tissue infiltration and delay wound contraction 
in a porcine excisional model. Journal ofBiomedical Materials Research Part 
B: Applied Biomaterials, 2015: n/a.
58
21. Weinzweig, J., ed. Plastic surgery Secrets Plus: The principles o f wound 
healing. 2010.
22. Balaji, A., Vellayappan, M. V., John, A. A., Subramanian, A. P., Jaganathan,
S. K., Supriyanto, E. and Razak, S. I. A. An insight on electrospun-nanofibers- 
inspired modern drug delivery system in the treatment of deadly cancers. RSC 
Adv, 2015. 5(71): 57984-58004.
23. Demir, M. M., Yilgor, I. and Erman B. Electrospinning of polyurethane fibers. 
Polymer, 2002. (43): 303-3309.
24. Kumbar, S. G., James, R., Nukavarapu, S. P. and Laurencin, C. T. Electrospun 
nanofiber scaffolds: engineering soft tissues. Biomedical Materials, 2008. 
3(3): 034002.
25. Myung-Seob Khil, Dong-Il Cha,Hak-Yong Kim, In-Shik Kim, Narayan 
Bhattarai. Electrospun nanofibrous polyurethane membrane as wound 
dressing. J Biomed Mater Res B Appl Biomater, 2003. (67(2)): 675-679.
26. Unnithan, A. R., Gnanasekaran, G., Sathishkumar, Y., Lee, Y. S. and Kim, 
C. S. Electrospun antibacterial polyurethane-cellulose acetate-zein composite 
mats for wound dressing. Carbohydrate Polymers, 2014. 102: 884-892.
27. Unnithan, A. R., Barakat, N. A., Tirupathi Pichiah, P., Gnanasekaran, G., 
Nirmala, R., Cha, Y.-S., Jung, C.-H., El-Newehy, M. and Kim, H. Y. Wound- 
dressing materials with antibacterial activity from electrospun polyurethane- 
dextran nanofiber mats containing ciprofloxacin HCl. Carbohydrate Polymers, 
2012. 90(4): 1786-1793.
28. Unnithan, A. R., Sasikala, A. R. K., Murugesan, P., Gurusamy, M., Wu, D., 
Park, C. H. and Kim, C. S. Electrospun polyurethane-dextran nanofiber mats 
loaded with Estradiol for post-menopausal wound dressing. International 
Journal o f Biological Macromolecules, 2015. 77: 1-8.
29. Chen JP, Chiang Y. Bioactive electrospun silver nanoparticles-containing 
polyurethane nanofibers as wound dressings. JNanosci Nanotechnol., 2010. 
(10(11)): 7560-7564.
30. Yuan, Z., Zhao, J., Chen, Y., Yang, Z., Cui, W. and Zheng, Q. Regulating 
Inflammation Using Acid-Responsive Electrospun Fibrous Scaffolds for Skin 
Scarless Healing. Mediators o f Inflammation, 2014. 2014(6): 1-11.
31. Marc Aprahamian MD, Alain Dentinger MD, Christiane Stock-Damge PhD, 
Jean-Claude Kouassi MD, Jacques F Grenier MD. Effects of supplemental 
pantothenic acid on wound healing: experimental study in rabbit. The 
American Journal o f Clinical Nutrition, 1985. (41): 578-589.
59
32. Jing, X., Mi, H.-Y., Salick, M. R., Cordie, T. M., Peng, X.-F. and Turng, 
L.-S. Electrospinning thermoplastic polyurethane/graphene oxide scaffolds 
for small diameter vascular graft applications. Materials Science and 
Engineering: C, 2015. 49: 40-50.
33. Amarnath, L. P., Srinivas, A. and Ramamurthi, A. In vitro hemocompatibility 
testing of UV-modified hyaluronan hydrogels. Biomaterials, 2006. 27(8): 
1416-1424.
34. Thirumal, M., Khastgir, D., Singha, N. K., Manjunath, B. S. and Naik, Y. P. 
Effect of foam density on the properties of water blown rigid polyurethane 
foam. Journal of Applied Polymer Science, 2008. 108(3): 1810-1817.
35. Rossmy, G., Kollmeier, H. J., Lidy, W., Schator, H. and Wiemann, M. 
Mechanism of the stabilization of flexible polyether polyurethane foams by 
silicone-based surfactants. Journal o f cellular plastics, 1981: 319-327.
36. Khil, M.-S., Cha, D.-I., Kim, H.-Y., Kim, I.-S. and Bhattarai, N. Electrospun 
nanofibrous polyurethane membrane as wound dressing. Wiley Periodicals, 
Inc. J  Biomed Mater Res Part B: Appl Biomater, 2003. (67B): 675-679.
37. Sabitha, M. and Rajiv, S. Preparation and characterization of ampicillin- 
incorporated electrospun polyurethane scaffolds for wound healing and 
infection control. Polymer Engineering & Science, 2015. 55(3): 541-548.
38. Kim, S. E., Heo, D. N., Lee, J. B., Kim, J. R., Park, S. H., Jeon, S. H. and 
Kwon, I. K. Electrospun gelatin/polyurethane blended nanofibers for wound 
healing. Biomedical Materials, 2009. 4(4): 044106.
39. Mi, H.-Y., Salick, M. R., Jing, X., Jacques, B. R., Crone, W. C., Peng, X.-F. and 
Turng, L.-S. Characterization of thermoplastic polyurethane/polylactic acid 
(TPU/PLA) tissue engineering scaffolds fabricated by microcellular injection 
molding. Materials Science and Engineering: C, 2013. 33(8): 4767-4776.
40. Meng, Z., Wang, Y., Ma, C., Zheng, W., Li, L. and Zheng, Y. Electrospinning 
of PLGA/gelatin randomly-oriented and aligned nanofibers as potential 
scaffold in tissue engineering. Materials Science and Engineering: C, 2010. 
30(8): 1204-1210.
41. Vaz, C., van Tuijl, S., Bouten, C. and Baaijens, F. Design of scaffolds for blood 
vessel tissue engineering using a multi-layering electrospinning technique. 
Acta Biomaterialia, 2005. 1(5): 575-582.
42. Jahani, H., Kaviani, S., Hassanpour-Ezatti, M., Soleimani, M., Kaviani, Z. and 
Zonoubi, Z. The Effect of Aligned and Random Electrospun Fibrous Scaffolds 
on Rat Mesenchymal Stem Cell Proliferation. Cell Journal(Yakhteh), Vol 14,
60
2011. (1): 31-38.
43. Das, B., Chattopadhyay, P., Mandal, M., Voit, B. and Karak, N. Bio-based
Biodegradable and Biocompatible Hyperbranched Polyurethane: A Scaffold 
for Tissue Engineering. Macromolecular Bioscience, 2013. 13(1): 126-139.
44. Wang, Y., Li, P., Xiang, P., Lu, J., Yuan, J. and Shen, J.
Electrospun polyurethane/keratin/AgNP biocomposite mats for biocompatible 
and antibacterial wound dressings. J. Mater. Chem. B, 2016. 4(4): 635-648.
45. Quiang, L. V., Chuanbao, C. and Hesun, Z. Blood compatibility of
polyurethane immobilized with acrylic acid and plasma grafting sulfonic acid. 
Journal o f Materials Science, Materials in Medicine, 2004. (15): 607-611.
46. Tanzi, M. C., Resnati, M., Lampugnani, M. G., Anouchinsky, R., Ambrosio,
L., Mambrito, B. and Dejana, E. Comparative biological tests on segmented
polyurethanes for cardio-vascular applications. Clinical materials, 1993. (12):
17-23.
47. Yang, H., Xu, H., Zhu, G., Ouyang, C., Wang, X. and Xu, W. Composite
membranes of native silk fibroin powder and biomedical polyurethane for 
controlled release of heparin. Proceedings o f the Institution o f Mechanical 
Engineers, Part H: Journal o f Engineering in Medicine, 2010. 1(1): 1-13.
48. Wang, R., Xiang, T., Zhao, W.-F. and Zhao, C.-S. A facile approach
toward multi-functional polyurethane/polyethersulfone composite membranes 
for versatile applications. Materials Science and Engineering: C, 2016. 59: 
556-564.
49. Korte, W., Clarke, S. and Lefkowitz, J. B. Short activated partial 
thromboplastin times are related to increased thrombin generation and an 
increased risk for thromboembolism. Am J Clin Pathol, 2000. (113): 123­
127.
50. Rhoades, R. and Bell, D. R. Medical physiology: Principles for clinical 
medicine. 3rd ed. Philadelphia: Lippincott Williams & Wilkins. 2009.
51. He, C., Wang, M., Cai, X., Huang, X., Li, L., Zhu, H., Shen, J. and Yuan, 
J. Chemically induced graft copolymerization of 2-hydroxyethyl methacrylate 
onto polyurethane surface for improving blood compatibility. Applied Surface 
Science, 2011. 258(2): 755-760.
52. Das, B., Chattopadhyay, P., Mishra, D., Maiti, T. K., Maji, S., 
Narayan, R. and Karak, N. Nanocomposites of bio-based hyperbranched 
polyurethane/funtionalized MWCNT as non-immunogenic, osteoconductive, 
biodegradable and biocompatible scaffolds in bone tissue engineering. Journal
61
o f Materials Chemistry B, 2013. 1(33): 4115.
53. Das, B., Mandal, M., Upadhyay, A., Chattopadhyay, P. and Karak, N. 
Bio-based hyperbranched polyurethane/Fe 3 O 4 nanocomposites: smart 
antibacterial biomaterials for biomedical devices and implants. Biomedical 
Materials, 2013. 8(3): 035003.
54. Belanger, M.-C., Marois, Y., Roy, R., Mehri, Y., Wagner, E., Zhang, Z., King, 
M. W., Yang, M., Hahn, C. and Guidoin, R. Selection of a Polyurethane 
Membrane for the Manufacture of Ventricles for a Totally Implantable 
Artificial Heart: Blood Compatibility and Biocampatibility Studies. Artificial 
Organs, 2000. (24(11)): 879-888.
55. Luo, Y., Zhang, C., Xu, F., Chen, Y., Fan, L. and Wei, Q. Synthesis and 
characterization of novel THTPBA/PEG-derived polyurethane scaffolds for 
tissue engineering. Journal o f Materials Science, 2010. 45(7): 1866-1877.
